LightPath Technologies, Inc. — Form 10-Q Summary
Business context and reporting period
LightPath designs and manufactures precision optical components and assemblies, including molded optics, infrared lenses and fiber-optic collimators. This unaudited filing covers the fiscal first quarter ended September 30, 2014; comparisons are with the three months ended September 30, 2013, unless otherwise noted.
Financial performance and liquidity
| Metric | Q1 FY2015 | Q1 FY2014 / comparison |
|---|---|---|
| Product sales | $2.60 million | $2.81 million; down 7% |
| Gross margin | $978,000; 38% | $1.32 million; 47% |
| Operating loss | $511,000 | $62,000 |
| Net loss | $579,000; $0.04 per share | $80,000; $0.01 per share |
| Adjusted EBITDA | $(380,000) | $168,000 |
| Operating cash flow | $(100,000) | $251,000 provided |
| Capital expenditures | $303,000 | $226,000 |
At September 30, 2014, cash was $787,000, total current assets were $6.92 million and current liabilities were $2.60 million, yielding working capital of approximately $4.32 million. Cash declined by $410,000 during the quarter. Total assets were $10.30 million and stockholders’ equity was $6.78 million.
Debt included approximately $156,000 outstanding on equipment advances under the Avidbank facility. Separately, the balance sheet carried a $785,000 warrant liability, remeasured through earnings. The company reported no outstanding revolving-line borrowing in the provided filing text.
Material changes and management commentary
- Sales and gross margin declined year over year. Management attributed lower sales mainly to reduced China laser-tool lens sales and a delayed order from a major U.S. defense contractor; increased infrared and GRADIUM sales partly offset the decline.
- Gross margin was pressured by higher wages during the China manufacturing transition, an infrared coating-vendor yield issue estimated to cost about $100,000, and approximately $50,000 of overlapping staffing costs. Management said the vendor issue was resolved and estimated these items reduced gross margin by about five percentage points.
- SG&A increased by approximately $67,000 to $1.14 million; new-product-development costs rose approximately $49,000 to $344,000. Management expects SG&A to remain generally near current levels and development spending to rise modestly for the rest of FY2015.
- Management reported a 12-month sales backlog of approximately $5.34 million, compared with $4.27 million at June 30, 2014. Bookings for low-cost lenses in Asia increased 73% year over year in the quarter.
- Production began at the Zhenjiang facility in April 2014, and the company is transitioning production from its Shanghai-area facility. Management expects sales growth for the remainder of FY2015 and, over the longer term, margins above prior levels as volumes, yields and production efficiencies improve. No specific numerical earnings or revenue guidance was provided.
Risks, contingencies and unusual items
- The company failed its minimum quick-ratio and debt-service-coverage covenants at September 30, 2014. A November 5, 2014 amendment waived both defaults. It also requires receipts to be deposited into a lockbox, with Avidbank able, at its discretion, to apply funds to amounts owed under the revolving line before releasing any remainder to the company. The revolving-line maturity was extended to December 30, 2014.
- Management said it believed available resources were adequate for its FY2015 operating plan and the coming year, but warned that unsuccessful efforts to achieve sales growth, positive cash flow and profitability could require additional capital. If financing is unavailable on reasonable terms, strategic alternatives could be considered.
- A proposed private placement to Pudong Investment remained subject to closing conditions, including governmental approvals. It is intended to bring the affiliated investors’ combined ownership to 14.9%; the purchase price is subject to adjustment but cannot be below $1.40 per share. Management estimated potential proceeds of about $1.51 million using the initial $1.62 price, subject to change.
- Management identified risks including limited cash resources and financing needs, dependence on a few key customers, execution of the transition into new markets, sales growth and cost control. The company reported effective disclosure controls and no material change in internal control over financial reporting; it reported no legal proceedings.
Important facts for investors to verify
- Whether sales, backlog conversion and Asian low-cost lens demand support management’s FY2015 growth expectations.
- Whether manufacturing relocation, infrared production ramp-up and resolved coating-yield problems deliver the expected margin and cash-flow improvements.
- The company’s liquidity and covenant status after the November 5 waiver, including the revolving-line maturity and lockbox provisions.
- Whether the Pudong placement closes, its final share price and proceeds, and the resulting dilution and ownership.
- Whether available cash and operating cash flow are sufficient to fund planned operations and capital needs without further financing.